 "Alembic Pharma surges on successful USFDA audit of Panelav API facilities")
Alembic Pharmaceuticals has surged 9% to Rs 595 on the BSE in intra-day trade after the company said the US health regulator conducted a successful inspection of its active pharmaceutical ingredient (API) facilities at Panelav, Gujarat this month.
“The company's API facilities i.e. API I and API II both located at Panelav have been successfully inspected by the United States Food and Drug Administration (USFDA) between June 20, 2016 and June 29, 2016,” Alembic Pharmaceuticals said in a BSE filing.
The Company did not receive any Form 483 observations, it added.
At 10:41 AM, the stock was up 7% at Rs 587 on the BSE. The trading volumes on the counter more than doubled with a combined 414,416 shares changed hands on the BSE and NSE so far.
“The company's API facilities i.e. API I and API II both located at Panelav have been successfully inspected by the United States Food and Drug Administration (USFDA) between June 20, 2016 and June 29, 2016,” Alembic Pharmaceuticals said in a BSE filing.
The Company did not receive any Form 483 observations, it added.
At 10:41 AM, the stock was up 7% at Rs 587 on the BSE. The trading volumes on the counter more than doubled with a combined 414,416 shares changed hands on the BSE and NSE so far.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%